Concepedia
Statistics
Publications
8
Citations
3.3K
H-Index
Active since
1991
Affiliations
GlaxoSmithKline (France)(Current)
GlaxoSmithKline (United Kingdom)
Molecular Discovery (United Kingdom)
GlaxoSmithKline (Brazil)
GlaxoSmithKline (Ireland)
Eric Boursier is an author at GlaxoSmithKline (France) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
1991–2016
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Dominique Toullec, P. Pianetti, Hervé Coste et al. · Journal of Biological Chemistry · 1991 · 2.5K citations · Full text
Pharmacy, Biochemistry, Pharmacology +11
Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
Chun‐wa Chung, Hervé Coste, Julia H. White et al. · Journal of Medicinal Chemistry · 2011 · 335 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +17
The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor
Romain Gosmini, Van Loc Nguyen, Jérôme Toum et al. · Journal of Medicinal Chemistry · 2014 · 187 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
Olivier Mirguet, Yann Lamotte, Frédéric Donche et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 118 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +6
Discovery, SAR, and X-ray Binding Mode Study of BCATm Inhibitors from a Novel DNA-Encoded Library
Hongfeng Deng, Jingye Zhou, Flora S. Sundersingh et al. · ACS Medicinal Chemistry Letters · 2015 · 84 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 8